Researchers identify a potential treatment to prevent severe COVID-19 in high-risk patients
UVA Health researchers have identified a potential treatment to prevent severe COVID-19 in patients at great risk.
Source: news-medical.net
📰 Barbaraj Mann News
Barbaraj Mann News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Barbaraj Mann. Real-time updates on events, politics, business and more.
Researchers track COVID-fighting antibodies after vaccination
The antibodies generated by Pfizer's COVID-19 vaccine rise more slowly and decline more quickly than those generated by the Moderna vaccine, according to a new study from UVA Health.
Source: news-medical.net
UVA study offers revealing look at efficacy of COVID vaccines
A new study from UVA Health finds that the antibodies generated by Pfizer’s COVID-19 vaccine rise more slowly and decline more quickly.
Source: augustafreepress.com
Business.Scoop » Study Tracks COVID-19 Antibodies Over Time
Business Scoop provides news and views on Business and Markets from New Zealand
Source: scoop.co.nz
Nasus Pharma Announces Clinical Data Demonstrating Efficacy of Taffix®, Intranasal Antiviral Protection Against Common Cold and Upper Respiratory Infection
/PRNewswire/ -- Nasus Pharma a privately held clinical-stage biopharmaceutical company developing a powder-based intranasal (PBI) product portfolio to address...
Source: prnewswire.com
Nasus Pharma Announces Clinical Data Demonstrating Efficacy of Taffix®, Intranasal Antiviral Protection Against Common Cold and Upper Respiratory Infection
/PRNewswire/ -- Nasus Pharma a privately held clinical-stage biopharmaceutical company developing a powder-based intranasal (PBI) product portfolio to address...
Source: prnewswire.com
Nasus Pharma Announces Clinical Data Demonstrating Efficacy of Taffix, Intranasal Antiviral Protection Against Common Cold and Upper Respiratory Infection
NP-003 study terminated early with high significance in reducing viral infection. TEL AVIV , Israel, Nov. 24, 2021 /PRNewswire/ -- Nasus Pharma a privately held clinical-stage biopharmaceutical
Source: finanznachrichten.de
Safety of Taffix reaffirmed
Safety of Taffix reaffirmed LONDON, March 17, 2021 /PRNewswire/ -- A leading biopharma company and makers of rapid delivery innovation for life-saving medicines - Nasus Pharma - stands behind its nasal spray, Taffix, reassuring the public of its safety and clinical efficacy. Taffix is built on an existing, proven, medical technology, which is already used in many nasal sprays to combat allergies and the common cold viruses. Contrary to the wording in an email regarding Taffix Nasal Spray sent t...
Source: finanznachrichten.de